Key result
Higher endogenous thrombin potential linked to ~31% lower odds of composite events.
Why the study?
Are acute-phase plasma levels of prothrombin fragment 1+2 (F1+2), D-dimer, and endogenous thrombin potential (ETP) associated with long-term composite cardiovascular events and total mortality in patients with STEMI treated with primary PCI?
Cohort (n=987)
No
Are acute-phase plasma levels of prothrombin fragment 1+2 (F1+2), D-dimer, and endogenous thrombin potential (ETP) associated with long-term composite cardiovascular events and total mortality in patients with STEMI treated with primary PCI?
Answers are grounded in this paper and cite their sources.
In STEMI patients treated with primary PCI, elevated acute-phase D-dimer independently predicts a two-fold higher risk of long-term all-cause mortality (with prognostic discrimination comparable to NT-proBNP), while lower ex vivo endogenous thrombin potential is independently associated with adverse composite cardiovascular outcomes.
Hypercoagulability in ST-segment elevation myocardial infarction (STEMI) as related to long-term clinical outcome is not clarified. We aimed to investigate whether prothrombin fragment 1+2 (F1+2), d-dimer, and endogenous thrombin potential (ETP) measured in the acute phase of STEMI were associated with outcome. Blood samples were drawn median 24 hours after symptom onset in 987 patients with STEMI. Median follow-up time was 4.6 years. Primary outcome was a composite of all-cause mortality, reinfarction, stroke, unscheduled revascularization, or rehospitalization for heart failure; secondary outcome was total mortality. The number of combined end points/total mortality was 195/79. Higher levels of d-dimer and F1+2 were observed with both end points (all P < .005), whereas ETP was significantly lower ( P < .01). Dichotomized at medians, increased risk was observed for levels above median for F1+2 and d-dimer (combined end point P = .020 and P = .010 and total mortality P < .001, both), while an inverse pattern was observed for ETP ( P < .02, both). Adjusting for covariates, d-dimer was still associated with reduced risk of total mortality ( P = .034) and receiver operating characteristic curve analyses showed area under the curve of 0.700 (95% confidence interval, 0.640-0.758). The hypercoagulable state in acute STEMI seems to be of importance for clinical outcome.
No takes yet. Share an insight, caveat, or question.
Hansen et al. (2018) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=987). Prothrombin fragment 1+2 (F1+2), D-dimer, and endogenous thrombin potential (ETP) measured in the acute phase (median 24 hours after symptom onset) vs. Levels below vs above population median (or across quartiles) was evaluated on Composite of all-cause mortality, reinfarction, stroke, unscheduled revascularization, or rehospitalization for heart failure (OR 0.688, 95% CI 0.484-0.980, p=0.038). Endogenous thrombin potential above the median was independently associated with reduced primary composite events, while elevated D-dimer predicted doubling of total mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: